Key result
Induced T2D exacerbates neointimal hyperplasia and luminal stenosis after carotid balloon injury in rats.
Why the study?
Existing animal models of diabetic macroangiopathy have limitations including complex genetic manipulation or long induction cycles.
The combined NAA/STZ and carotid balloon injury model in SD rats successfully and rapidly recapitulates diabetic macroangiopathy pathology, providing a suitable platform for therapeutic investigation.
Provides viable rat model for diabetic macroangiopathy research; leaves open translation to human therapies.
Purpose: Diabetic macroangiopathy is a leading cause of disability and mortality in type 2 diabetes mellitus (T2DM) patients, but existing animal models have limitations such as complex genetic manipulation or long induction cycles. This study constructed and evaluated a combined model of nicotinamide (NAA)/streptozotocin (STZ)-induced T2DM and carotid balloon injury in Sprague-Dawley (SD) rats. Methods: Sixty male SD rats were divided into four groups: control, VBI (only vascular balloon injury), T2DM (only NAA/STZ-induced T2DM), and T2DM+VBI (combined model) groups. T2DM was induced via NAA (110 mg/kg) followed by STZ (65 mg/kg); VBI was performed via a percutaneous transluminal coronary angioplasty (PTCA) balloon catheter. Over 6 weeks, metabolic indicators [intake, excretion, body weight, and random blood glucose (RBG)] were monitored; carotid tissues were collected at 2, 4, and 6 weeks post-VBI for HE staining and immunohistochemistry (α-SMA, F4/80, and MMP-9); and blood cell counts and plasma biochemistry were analyzed. Results: The T2DM induction success rate was 90% (no mortality); the postoperative mortality rate was 14.3% in the T2DM+VBI group (vs. 7% in the VBI group). The T2DM and T2DM+VBI groups presented typical diabetic symptoms and persistent hyperglycemia. Histologically, only the VBI and T2DM+VBI groups exhibited time-dependent neointimal proliferation, with T2DM+VBI exhibiting a larger neointimal area, a greater proliferation index, more severe luminal stenosis (2-week hyperplasia comparable to VBI 6 weeks) and increased F4/80-positive macrophages/MMP-9 (poor plaque stability). No major organ abnormalities (except T2DM hepatic steatosis) or intergroup blood parameter differences were found. Conclusion: This combined model has stable hyperglycemia, obvious neointimal hyperplasia, rapid modeling and a high success rate (optimal observation window: 2-4 weeks post-VBI). It recapitulates diabetic macroangiopathy pathology and is suitable for investigating therapeutic efficacy and related molecular/cellular mechanisms.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Diabetic macroangiopathy (n=60). NAA/STZ-induced T2DM + carotid balloon injury vs. Vascular balloon injury (VBI) alone, T2DM alone, and normal control was evaluated on Neointimal area, proliferation index, and stenosis percentage (p=<0.01). The combined model of NAA/STZ-induced type 2 diabetes and carotid balloon injury in rats exhibited significantly greater neointimal hyperplasia and luminal stenosis compared to balloon injury alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: